1. Home
  2. RMD vs BNTX Comparison

RMD vs BNTX Comparison

Compare RMD & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$210.27

Market Cap

28.4B

Sector

Health Care

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$91.19

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMD
BNTX
Founded
1989
2008
Country
United States
Germany
Employees
10600
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.4B
24.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RMD
BNTX
Price
$210.27
$91.19
Analyst Decision
Buy
Strong Buy
Analyst Count
10
13
Target Price
$292.56
$133.46
AVG Volume (30 Days)
1.3M
763.5K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
1.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.60
N/A
Revenue Next Year
$7.41
$3.37
P/E Ratio
$25.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$180.27
$79.81
52 Week High
$293.81
$124.00

Technical Indicators

Market Signals
Indicator
RMD
BNTX
Relative Strength Index (RSI) 57.00 47.17
Support Level $198.63 $90.95
Resistance Level $211.74 $94.10
Average True Range (ATR) 5.20 2.21
MACD 1.35 0.00
Stochastic Oscillator 76.99 44.93

Price Performance

Historical Comparison
RMD
BNTX

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: